의학
Early University of Calgary trial tests high-dose niacin as add-on treatment for glioblastoma
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
Researchers at the University of Calgary are studying whether high doses of vitamin B3 (niacin) can improve outcomes for patients with newly diagnosed glioblastoma when added to standard treatment. An interim analysis of 24 patients found a higher-than-expected six‑month progression‑free survival rate, though investigators stress the results are preliminary and require ongoing safety monitoring.
A study has identified how an existing medication could improve immunotherapy outcomes for fibrolamellar carcinoma. The rare liver cancer currently has no cure and often spreads before detection. Researchers demonstrated the approach using patient tumor samples.
AI에 의해 보고됨 사실 확인됨
A Newcastle University-led screening study of nearly 300 adults in northern Britain found persistently high rates of low vitamin D in older people and adults from minoritized ethnic groups, with little evidence that summer months substantially improved levels.
Researchers at the University of California, Riverside have proposed that amyloid beta disrupts tau protein function inside neurons, potentially triggering Alzheimer's disease. The findings challenge the focus on external plaques as the primary cause.
AI에 의해 보고됨
Two existing medications cooled core body temperature in animals after stroke and reduced brain damage. A small human trial showed limited effect due to slow delivery. Researchers are now planning a follow-up study with faster infusions.
Medical technology company SpectraCure in Lund is carrying out a rights issue that will add 34.2 million kronor if fully subscribed. The issue will finance clinical studies and regulatory applications. The share fell more than 20 percent on Monday.
AI에 의해 보고됨 사실 확인됨
Adults with obesity who began taking GLP-1 receptor agonist medications showed declines in Fitbit-measured physical activity after starting treatment, according to a retrospective study presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago.
Oestrogen fluctuations may affect brain drug delivery in women
2026년 06월 24일 08시 50분French startup develops polymer liquid to aid nerve healing
2026년 06월 22일 15시 15분Woman with Alzheimer's regains speech after psilocybin treatment
2026년 06월 20일 12시 05분Study finds excessive EXO1 DNA-repair activity can destabilize genomes and may mark tumors sensitive to some therapies
2026년 06월 20일 04시 21분Updated POWER framework urges multidisciplinary obesity care beyond GLP-1 drugs
2026년 06월 17일 13시 42분Study reveals hidden regenerative powers in mammals
2026년 06월 17일 07시 31분Study finds genicular artery embolization reduced knee osteoarthritis pain for at least 12 months
2026년 06월 16일 12시 55분Study presented at ENDO 2026 links semaglutide to fewer fractures in people with type 2 diabetes
2026년 06월 16일 07시 37분Claims-data study finds many people with type 2 diabetes restart GLP-1 drugs after stopping
2026년 06월 15일 19시 53분Review finds calcium and vitamin D supplements offer little benefit